nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.194	0.277	CbGbCtD
Fidaxomicin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.173	0.247	CbGbCtD
Fidaxomicin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.125	0.179	CbGbCtD
Fidaxomicin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0859	0.123	CbGbCtD
Fidaxomicin—ABCB1—Glyburide—type 2 diabetes mellitus	0.064	0.0914	CbGbCtD
Fidaxomicin—ABCB1—Losartan—type 2 diabetes mellitus	0.0586	0.0836	CbGbCtD
Fidaxomicin—Nausea—Acarbose—type 2 diabetes mellitus	0.000748	0.0025	CcSEcCtD
Fidaxomicin—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000747	0.00249	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.000746	0.00249	CcSEcCtD
Fidaxomicin—Constipation—Glipizide—type 2 diabetes mellitus	0.000744	0.00248	CcSEcCtD
Fidaxomicin—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000744	0.00248	CcSEcCtD
Fidaxomicin—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000743	0.00248	CcSEcCtD
Fidaxomicin—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000736	0.00246	CcSEcCtD
Fidaxomicin—Flatulence—Gliclazide—type 2 diabetes mellitus	0.000726	0.00242	CcSEcCtD
Fidaxomicin—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000724	0.00242	CcSEcCtD
Fidaxomicin—Nausea—Nateglinide—type 2 diabetes mellitus	0.000721	0.00241	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000719	0.0024	CcSEcCtD
Fidaxomicin—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000718	0.0024	CcSEcCtD
Fidaxomicin—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000714	0.00239	CcSEcCtD
Fidaxomicin—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000712	0.00238	CcSEcCtD
Fidaxomicin—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000711	0.00238	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000711	0.00238	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000708	0.00237	CcSEcCtD
Fidaxomicin—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000705	0.00236	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000704	0.00235	CcSEcCtD
Fidaxomicin—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000703	0.00235	CcSEcCtD
Fidaxomicin—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000703	0.00235	CcSEcCtD
Fidaxomicin—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000702	0.00234	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000701	0.00234	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000698	0.00233	CcSEcCtD
Fidaxomicin—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000694	0.00232	CcSEcCtD
Fidaxomicin—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000692	0.00231	CcSEcCtD
Fidaxomicin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000687	0.0023	CcSEcCtD
Fidaxomicin—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000681	0.00227	CcSEcCtD
Fidaxomicin—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000677	0.00226	CcSEcCtD
Fidaxomicin—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000673	0.00225	CcSEcCtD
Fidaxomicin—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000673	0.00225	CcSEcCtD
Fidaxomicin—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000669	0.00223	CcSEcCtD
Fidaxomicin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000668	0.00223	CcSEcCtD
Fidaxomicin—Flatulence—Valsartan—type 2 diabetes mellitus	0.000667	0.00223	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000664	0.00222	CcSEcCtD
Fidaxomicin—Rash—Repaglinide—type 2 diabetes mellitus	0.000663	0.00221	CcSEcCtD
Fidaxomicin—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000663	0.00221	CcSEcCtD
Fidaxomicin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000662	0.00221	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000662	0.00221	CcSEcCtD
Fidaxomicin—Flatulence—Orlistat—type 2 diabetes mellitus	0.000659	0.0022	CcSEcCtD
Fidaxomicin—Headache—Repaglinide—type 2 diabetes mellitus	0.000658	0.0022	CcSEcCtD
Fidaxomicin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000657	0.00219	CcSEcCtD
Fidaxomicin—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000656	0.00219	CcSEcCtD
Fidaxomicin—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000655	0.00219	CcSEcCtD
Fidaxomicin—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000653	0.00218	CcSEcCtD
Fidaxomicin—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000644	0.00215	CcSEcCtD
Fidaxomicin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000642	0.00214	CcSEcCtD
Fidaxomicin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000641	0.00214	CcSEcCtD
Fidaxomicin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00064	0.00214	CcSEcCtD
Fidaxomicin—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000639	0.00214	CcSEcCtD
Fidaxomicin—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000636	0.00213	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000632	0.00211	CcSEcCtD
Fidaxomicin—Neutropenia—Ramipril—type 2 diabetes mellitus	0.00063	0.0021	CcSEcCtD
Fidaxomicin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000626	0.00209	CcSEcCtD
Fidaxomicin—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000626	0.00209	CcSEcCtD
Fidaxomicin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000626	0.00209	CcSEcCtD
Fidaxomicin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000624	0.00209	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000623	0.00208	CcSEcCtD
Fidaxomicin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000622	0.00208	CcSEcCtD
Fidaxomicin—Angioedema—Valsartan—type 2 diabetes mellitus	0.000618	0.00206	CcSEcCtD
Fidaxomicin—Malnutrition—Metformin—type 2 diabetes mellitus	0.000616	0.00206	CcSEcCtD
Fidaxomicin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000615	0.00206	CcSEcCtD
Fidaxomicin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000614	0.00205	CcSEcCtD
Fidaxomicin—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000613	0.00205	CcSEcCtD
Fidaxomicin—Angioedema—Orlistat—type 2 diabetes mellitus	0.000611	0.00204	CcSEcCtD
Fidaxomicin—Flatulence—Metformin—type 2 diabetes mellitus	0.000607	0.00203	CcSEcCtD
Fidaxomicin—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000603	0.00202	CcSEcCtD
Fidaxomicin—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000603	0.00202	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000599	0.002	CcSEcCtD
Fidaxomicin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000598	0.002	CcSEcCtD
Fidaxomicin—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000597	0.00199	CcSEcCtD
Fidaxomicin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000596	0.00199	CcSEcCtD
Fidaxomicin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00059	0.00197	CcSEcCtD
Fidaxomicin—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000589	0.00197	CcSEcCtD
Fidaxomicin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000589	0.00197	CcSEcCtD
Fidaxomicin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000584	0.00195	CcSEcCtD
Fidaxomicin—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000582	0.00194	CcSEcCtD
Fidaxomicin—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000581	0.00194	CcSEcCtD
Fidaxomicin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000579	0.00193	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000578	0.00193	CcSEcCtD
Fidaxomicin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000575	0.00192	CcSEcCtD
Fidaxomicin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000574	0.00192	CcSEcCtD
Fidaxomicin—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000573	0.00191	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000572	0.00191	CcSEcCtD
Fidaxomicin—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000569	0.0019	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000568	0.0019	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000565	0.00189	CcSEcCtD
Fidaxomicin—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000563	0.00188	CcSEcCtD
Fidaxomicin—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000557	0.00186	CcSEcCtD
Fidaxomicin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000553	0.00185	CcSEcCtD
Fidaxomicin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000551	0.00184	CcSEcCtD
Fidaxomicin—Rash—Glipizide—type 2 diabetes mellitus	0.000548	0.00183	CcSEcCtD
Fidaxomicin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000548	0.00183	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000547	0.00183	CcSEcCtD
Fidaxomicin—Headache—Glipizide—type 2 diabetes mellitus	0.000545	0.00182	CcSEcCtD
Fidaxomicin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000541	0.00181	CcSEcCtD
Fidaxomicin—Flatulence—Losartan—type 2 diabetes mellitus	0.000539	0.0018	CcSEcCtD
Fidaxomicin—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000537	0.00179	CcSEcCtD
Fidaxomicin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000537	0.00179	CcSEcCtD
Fidaxomicin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000536	0.00179	CcSEcCtD
Fidaxomicin—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000536	0.00179	CcSEcCtD
Fidaxomicin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000536	0.00179	CcSEcCtD
Fidaxomicin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000535	0.00179	CcSEcCtD
Fidaxomicin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000535	0.00179	CcSEcCtD
Fidaxomicin—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000531	0.00177	CcSEcCtD
Fidaxomicin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00053	0.00177	CcSEcCtD
Fidaxomicin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000529	0.00177	CcSEcCtD
Fidaxomicin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000529	0.00177	CcSEcCtD
Fidaxomicin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000522	0.00174	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000521	0.00174	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000519	0.00173	CcSEcCtD
Fidaxomicin—Nausea—Glipizide—type 2 diabetes mellitus	0.000517	0.00173	CcSEcCtD
Fidaxomicin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000516	0.00172	CcSEcCtD
Fidaxomicin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000514	0.00172	CcSEcCtD
Fidaxomicin—Constipation—Gliclazide—type 2 diabetes mellitus	0.000514	0.00172	CcSEcCtD
Fidaxomicin—Rash—Glimepiride—type 2 diabetes mellitus	0.000512	0.00171	CcSEcCtD
Fidaxomicin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000511	0.00171	CcSEcCtD
Fidaxomicin—Rash—Sitagliptin—type 2 diabetes mellitus	0.00051	0.0017	CcSEcCtD
Fidaxomicin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00051	0.0017	CcSEcCtD
Fidaxomicin—Headache—Glimepiride—type 2 diabetes mellitus	0.000508	0.0017	CcSEcCtD
Fidaxomicin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000507	0.00169	CcSEcCtD
Fidaxomicin—Anaemia—Losartan—type 2 diabetes mellitus	0.000506	0.00169	CcSEcCtD
Fidaxomicin—Angioedema—Losartan—type 2 diabetes mellitus	0.0005	0.00167	CcSEcCtD
Fidaxomicin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000493	0.00165	CcSEcCtD
Fidaxomicin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000493	0.00165	CcSEcCtD
Fidaxomicin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000492	0.00164	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000492	0.00164	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000491	0.00164	CcSEcCtD
Fidaxomicin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000488	0.00163	CcSEcCtD
Fidaxomicin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000487	0.00163	CcSEcCtD
Fidaxomicin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000486	0.00162	CcSEcCtD
Fidaxomicin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000484	0.00162	CcSEcCtD
Fidaxomicin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000484	0.00162	CcSEcCtD
Fidaxomicin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000482	0.00161	CcSEcCtD
Fidaxomicin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000481	0.00161	CcSEcCtD
Fidaxomicin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00048	0.0016	CcSEcCtD
Fidaxomicin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00048	0.0016	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000477	0.00159	CcSEcCtD
Fidaxomicin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000475	0.00159	CcSEcCtD
Fidaxomicin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000474	0.00158	CcSEcCtD
Fidaxomicin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000474	0.00158	CcSEcCtD
Fidaxomicin—Constipation—Valsartan—type 2 diabetes mellitus	0.000472	0.00158	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000471	0.00157	CcSEcCtD
Fidaxomicin—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000469	0.00157	CcSEcCtD
Fidaxomicin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000466	0.00155	CcSEcCtD
Fidaxomicin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000465	0.00155	CcSEcCtD
Fidaxomicin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000462	0.00154	CcSEcCtD
Fidaxomicin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000461	0.00154	CcSEcCtD
Fidaxomicin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000461	0.00154	CcSEcCtD
Fidaxomicin—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000459	0.00153	CcSEcCtD
Fidaxomicin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000459	0.00153	CcSEcCtD
Fidaxomicin—Dry mouth—Losartan—type 2 diabetes mellitus	0.000456	0.00152	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000452	0.00151	CcSEcCtD
Fidaxomicin—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000448	0.0015	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000446	0.00149	CcSEcCtD
Fidaxomicin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000443	0.00148	CcSEcCtD
Fidaxomicin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000443	0.00148	CcSEcCtD
Fidaxomicin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000438	0.00146	CcSEcCtD
Fidaxomicin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000437	0.00146	CcSEcCtD
Fidaxomicin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000436	0.00146	CcSEcCtD
Fidaxomicin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000435	0.00145	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000434	0.00145	CcSEcCtD
Fidaxomicin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000431	0.00144	CcSEcCtD
Fidaxomicin—Constipation—Metformin—type 2 diabetes mellitus	0.00043	0.00144	CcSEcCtD
Fidaxomicin—Angioedema—Ramipril—type 2 diabetes mellitus	0.000429	0.00143	CcSEcCtD
Fidaxomicin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000426	0.00142	CcSEcCtD
Fidaxomicin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000425	0.00142	CcSEcCtD
Fidaxomicin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000423	0.00141	CcSEcCtD
Fidaxomicin—Rash—Glyburide—type 2 diabetes mellitus	0.000422	0.00141	CcSEcCtD
Fidaxomicin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000422	0.00141	CcSEcCtD
Fidaxomicin—Headache—Glyburide—type 2 diabetes mellitus	0.000419	0.0014	CcSEcCtD
Fidaxomicin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000418	0.0014	CcSEcCtD
Fidaxomicin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000412	0.00138	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000411	0.00137	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00041	0.00137	CcSEcCtD
Fidaxomicin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000407	0.00136	CcSEcCtD
Fidaxomicin—Constipation—Irbesartan—type 2 diabetes mellitus	0.000406	0.00136	CcSEcCtD
Fidaxomicin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000402	0.00134	CcSEcCtD
Fidaxomicin—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000398	0.00133	CcSEcCtD
Fidaxomicin—Nausea—Glyburide—type 2 diabetes mellitus	0.000398	0.00133	CcSEcCtD
Fidaxomicin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000397	0.00133	CcSEcCtD
Fidaxomicin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000397	0.00133	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000397	0.00132	CcSEcCtD
Fidaxomicin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000393	0.00131	CcSEcCtD
Fidaxomicin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000391	0.0013	CcSEcCtD
Fidaxomicin—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000391	0.0013	CcSEcCtD
Fidaxomicin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000388	0.0013	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000388	0.0013	CcSEcCtD
Fidaxomicin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000386	0.00129	CcSEcCtD
Fidaxomicin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000382	0.00128	CcSEcCtD
Fidaxomicin—Constipation—Losartan—type 2 diabetes mellitus	0.000382	0.00128	CcSEcCtD
Fidaxomicin—Rash—Gliclazide—type 2 diabetes mellitus	0.000379	0.00127	CcSEcCtD
Fidaxomicin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000379	0.00126	CcSEcCtD
Fidaxomicin—Headache—Gliclazide—type 2 diabetes mellitus	0.000376	0.00126	CcSEcCtD
Fidaxomicin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000376	0.00125	CcSEcCtD
Fidaxomicin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000375	0.00125	CcSEcCtD
Fidaxomicin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000372	0.00124	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000365	0.00122	CcSEcCtD
Fidaxomicin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000365	0.00122	CcSEcCtD
Fidaxomicin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000361	0.00121	CcSEcCtD
Fidaxomicin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000357	0.00119	CcSEcCtD
Fidaxomicin—Pruritus—Metformin—type 2 diabetes mellitus	0.000356	0.00119	CcSEcCtD
Fidaxomicin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000353	0.00118	CcSEcCtD
Fidaxomicin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000351	0.00117	CcSEcCtD
Fidaxomicin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00035	0.00117	CcSEcCtD
Fidaxomicin—Rash—Valsartan—type 2 diabetes mellitus	0.000348	0.00116	CcSEcCtD
Fidaxomicin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000348	0.00116	CcSEcCtD
Fidaxomicin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000347	0.00116	CcSEcCtD
Fidaxomicin—Headache—Valsartan—type 2 diabetes mellitus	0.000346	0.00116	CcSEcCtD
Fidaxomicin—Rash—Orlistat—type 2 diabetes mellitus	0.000344	0.00115	CcSEcCtD
Fidaxomicin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000344	0.00115	CcSEcCtD
Fidaxomicin—Headache—Orlistat—type 2 diabetes mellitus	0.000342	0.00114	CcSEcCtD
Fidaxomicin—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000341	0.00114	CcSEcCtD
Fidaxomicin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000337	0.00113	CcSEcCtD
Fidaxomicin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000336	0.00112	CcSEcCtD
Fidaxomicin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000333	0.00111	CcSEcCtD
Fidaxomicin—Dizziness—Metformin—type 2 diabetes mellitus	0.000333	0.00111	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000331	0.0011	CcSEcCtD
Fidaxomicin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000329	0.0011	CcSEcCtD
Fidaxomicin—Nausea—Valsartan—type 2 diabetes mellitus	0.000328	0.0011	CcSEcCtD
Fidaxomicin—Constipation—Ramipril—type 2 diabetes mellitus	0.000327	0.00109	CcSEcCtD
Fidaxomicin—Nausea—Orlistat—type 2 diabetes mellitus	0.000324	0.00108	CcSEcCtD
Fidaxomicin—Vomiting—Metformin—type 2 diabetes mellitus	0.00032	0.00107	CcSEcCtD
Fidaxomicin—Rash—Metformin—type 2 diabetes mellitus	0.000317	0.00106	CcSEcCtD
Fidaxomicin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000317	0.00106	CcSEcCtD
Fidaxomicin—Pruritus—Losartan—type 2 diabetes mellitus	0.000316	0.00106	CcSEcCtD
Fidaxomicin—Headache—Metformin—type 2 diabetes mellitus	0.000315	0.00105	CcSEcCtD
Fidaxomicin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000314	0.00105	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000313	0.00105	CcSEcCtD
Fidaxomicin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000303	0.00101	CcSEcCtD
Fidaxomicin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000302	0.00101	CcSEcCtD
Fidaxomicin—Rash—Irbesartan—type 2 diabetes mellitus	0.000299	0.000999	CcSEcCtD
Fidaxomicin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000299	0.000998	CcSEcCtD
Fidaxomicin—Nausea—Metformin—type 2 diabetes mellitus	0.000299	0.000998	CcSEcCtD
Fidaxomicin—Headache—Irbesartan—type 2 diabetes mellitus	0.000297	0.000993	CcSEcCtD
Fidaxomicin—Dizziness—Losartan—type 2 diabetes mellitus	0.000295	0.000986	CcSEcCtD
Fidaxomicin—Vomiting—Losartan—type 2 diabetes mellitus	0.000284	0.000948	CcSEcCtD
Fidaxomicin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000282	0.000942	CcSEcCtD
Fidaxomicin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000282	0.000941	CcSEcCtD
Fidaxomicin—Rash—Losartan—type 2 diabetes mellitus	0.000282	0.00094	CcSEcCtD
Fidaxomicin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000281	0.00094	CcSEcCtD
Fidaxomicin—Headache—Losartan—type 2 diabetes mellitus	0.00028	0.000934	CcSEcCtD
Fidaxomicin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000271	0.000905	CcSEcCtD
Fidaxomicin—Nausea—Losartan—type 2 diabetes mellitus	0.000265	0.000886	CcSEcCtD
Fidaxomicin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000253	0.000846	CcSEcCtD
Fidaxomicin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000243	0.000813	CcSEcCtD
Fidaxomicin—Rash—Ramipril—type 2 diabetes mellitus	0.000241	0.000806	CcSEcCtD
Fidaxomicin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000241	0.000806	CcSEcCtD
Fidaxomicin—Headache—Ramipril—type 2 diabetes mellitus	0.00024	0.000801	CcSEcCtD
Fidaxomicin—Nausea—Ramipril—type 2 diabetes mellitus	0.000227	0.00076	CcSEcCtD
